Labcorp rapidly expanding its COVID-19 testing capacity, expects ability to perform 10,000 tests per day by the end of the week and 20,000 tests per day by the end of March

MARCH 16, 2020 - 8:45 A.M.

Labcorp is rapidly expanding its 2019 Novel Coronavirus (COVID-19) testing capacity and expects the ability to perform more than 10,000 tests per day by the end of the week and 20,000 tests per day by the end of March. We have been working closely with the government and others to increase test capacity and respond to this public health crisis. Our utmost concern is for the safety of the public, patients, healthcare service providers, and our employees, and we are proud to play an important role as part of an industry consortium that is committed to meeting the growing demand for national testing.

As part of the industry response, LabCorp is working with other labs through its trade association, the American Clinical Laboratory Association (ACLA), to rapidly expand capacity across the country. As ACLA estimates in a media statement issued March 13: “Once additional FDA-approved high-throughput testing is available on large diagnostic platforms next week, the industry expects its capacity to be increased to more than 20,000 tests per day. Assuming there are no delays or shortages of necessary materials and supplies, commercial capacity is expected to exceed 280,000 tests per week by April 1.”